Drugs / interferon α1b
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06212388 | Jan 2024 → Oct 2027 expected | melanoma | Xijing Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | interferon α1b | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06212388 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant human interferon α1b is a protein” NCT06212388 ↗ |